Three Cleveland Clinic cardiologists size up the ACC/AHA recommendations
‘A gateway to...a new range of therapies for atherosclerosis’
Daylong course in Cleveland on Nov. 3, 2017
Beyond the headlines on CANTOS, REVEAL, COMPASS
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Celecoxib has least impact, followed by naproxen and ibuprofen
The stakes of — and reasons behind — the ‘cult of statin denial’
Internet-fueled misinformation demands broad physician response
Dr. Steven Nissen shares his take
Q&A with Steven Nissen on the advent of diabetes drugs that curb cardiac events
GLAGOV results boost hopes for coming outcome trials